Search

Your search keyword '"Spence, Mark S"' showing total 377 results

Search Constraints

Start Over You searched for: Author "Spence, Mark S" Remove constraint Author: "Spence, Mark S"
377 results on '"Spence, Mark S"'

Search Results

1. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

4. Sex-Specific Clinical Outcomes After Treatment of Left Main Coronary Artery Disease. A NOBLE Substudy

11. Transcatheter Aortic Valve Replacement With the LOTUS Edge System: Early European Experience

13. Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR: A Multicenter Registry

21. Long-Term Durability of Transcatheter Aortic Valve Prostheses

22. Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week

24. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort)

25. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience

26. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

27. Redo aortic valve replacement vs valve-in-valve trans-catheter aortic valve implantation: a UK propensity-matched analysis

28. An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group

30. Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial

31. Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Valve: United Kingdom Experience

32. Contributors

34. Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial

35. Long‐term durability of self‐expanding and balloon‐expandable transcatheter aortic valve prostheses: UK TAVI registry.

36. Same-Day Discharge Post–Transcatheter Aortic Valve Replacement During the COVID-19 Pandemic

37. Risk of infective endocarditis after surgical and transcatheter aortic valve replacement

43. Cover Image

44. Setting a benchmark for resource utilization and quality of care in patients undergoing transcatheter aortic valve implantation in Europe—Rationale and design of the international BENCHMARK registry

49. Transcatheter Aortic Valve Replacement With the LOTUS Edge System:Early European Experience

Catalog

Books, media, physical & digital resources